Cell culture media notably influence properties of human mesenchymal stroma/stem-like cells from different tissues.


Journal

Cytotherapy
ISSN: 1477-2566
Titre abrégé: Cytotherapy
Pays: England
ID NLM: 100895309

Informations de publication

Date de publication:
11 2020
Historique:
received: 31 03 2020
revised: 06 07 2020
accepted: 09 07 2020
pubmed: 29 8 2020
medline: 13 2 2021
entrez: 29 8 2020
Statut: ppublish

Résumé

Mesenchymal stroma/stem-like cells (MSCs) are a popular cell source and hold huge therapeutic promise for a broad range of possible clinical applications. However, to harness their full potential, current limitations in harvesting, expansion and characterization have to be overcome. These limitations are related to the heterogeneity of MSCs in general as well as to inconsistent experimental protocols. Here we aim to compare in vitro methods to facilitate comparison of MSCs generated from various tissues. MSCs from 3 different tissues (bone marrow, dental pulp, adipose tissue), exemplified by cells from 3 randomly chosen donors per tissue, were systematically compared with respect to their in vitro properties after propagation in specific in-house standard media, as established in the individual laboratories, or in the same commercially available medium. Large differences were documented with respect to the expression of cell surface antigens, population doubling times, basal expression levels of 5 selected genes and osteogenic differentiation. The commercial medium reduced differences in these parameters with respect to individual human donors within tissue and between tissues. The extent, size and tetraspanin composition of extracellular vesicles were also affected. The results clearly demonstrate the extreme heterogeneity of MSCs, which confirms the problem of reproducibility of results, even when harmonizing experimental conditions, and questions the significance of common parameters for MSCs from different tissues in vitro.

Sections du résumé

BACKGROUND AIMS
Mesenchymal stroma/stem-like cells (MSCs) are a popular cell source and hold huge therapeutic promise for a broad range of possible clinical applications. However, to harness their full potential, current limitations in harvesting, expansion and characterization have to be overcome. These limitations are related to the heterogeneity of MSCs in general as well as to inconsistent experimental protocols. Here we aim to compare in vitro methods to facilitate comparison of MSCs generated from various tissues.
METHODS
MSCs from 3 different tissues (bone marrow, dental pulp, adipose tissue), exemplified by cells from 3 randomly chosen donors per tissue, were systematically compared with respect to their in vitro properties after propagation in specific in-house standard media, as established in the individual laboratories, or in the same commercially available medium.
RESULTS
Large differences were documented with respect to the expression of cell surface antigens, population doubling times, basal expression levels of 5 selected genes and osteogenic differentiation. The commercial medium reduced differences in these parameters with respect to individual human donors within tissue and between tissues. The extent, size and tetraspanin composition of extracellular vesicles were also affected.
CONCLUSIONS
The results clearly demonstrate the extreme heterogeneity of MSCs, which confirms the problem of reproducibility of results, even when harmonizing experimental conditions, and questions the significance of common parameters for MSCs from different tissues in vitro.

Identifiants

pubmed: 32855067
pii: S1465-3249(20)30792-1
doi: 10.1016/j.jcyt.2020.07.005
pii:
doi:

Substances chimiques

Antigens, Surface 0
Biomarkers 0
Culture Media 0
Tetraspanins 0
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

653-668

Informations de copyright

Copyright © 2020 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.

Auteurs

Andreas Winkel (A)

Department of Prosthetic Dentistry and Biomedical Materials Science, Hannover Medical School, Hannover, Germany; Lower Saxony Centre for Biomedical Engineering, Implant Research and Development (NIFE), Hannover, Germany.

Yarúa Jaimes (Y)

Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany; Institute for Clinical Immunology, University of Leipzig, Leipzig, Germany.

Catharina Melzer (C)

Biochemistry and Tumour Biology Laboratory, Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.

Philipp Dillschneider (P)

Department of Prosthetic Dentistry and Biomedical Materials Science, Hannover Medical School, Hannover, Germany; Lower Saxony Centre for Biomedical Engineering, Implant Research and Development (NIFE), Hannover, Germany.

Henning Hartwig (H)

Department of Prosthetic Dentistry and Biomedical Materials Science, Hannover Medical School, Hannover, Germany; Lower Saxony Centre for Biomedical Engineering, Implant Research and Development (NIFE), Hannover, Germany.

Meike Stiesch (M)

Department of Prosthetic Dentistry and Biomedical Materials Science, Hannover Medical School, Hannover, Germany; Lower Saxony Centre for Biomedical Engineering, Implant Research and Development (NIFE), Hannover, Germany.

Juliane von der Ohe (J)

Biochemistry and Tumour Biology Laboratory, Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.

Sarah Strauss (S)

Department of Plastic, Aesthetic, Hand and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.

Peter M Vogt (PM)

Department of Plastic, Aesthetic, Hand and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.

Anika Hamm (A)

Department of Orthopaedic Surgery, Graded Implants and Regenerative Strategies, Hannover Medical School, Hannover, Germany; Lower Saxony Centre for Biomedical Engineering, Implant Research and Development (NIFE), Hannover, Germany.

Laura Burmeister (L)

Department of Orthopaedic Surgery, Graded Implants and Regenerative Strategies, Hannover Medical School, Hannover, Germany; Lower Saxony Centre for Biomedical Engineering, Implant Research and Development (NIFE), Hannover, Germany.

Yvonne Roger (Y)

Department of Orthopaedic Surgery, Graded Implants and Regenerative Strategies, Hannover Medical School, Hannover, Germany; Lower Saxony Centre for Biomedical Engineering, Implant Research and Development (NIFE), Hannover, Germany.

Kirsten Elger (K)

Department of Orthopaedic Surgery, Graded Implants and Regenerative Strategies, Hannover Medical School, Hannover, Germany; Lower Saxony Centre for Biomedical Engineering, Implant Research and Development (NIFE), Hannover, Germany.

Thilo Floerkemeier (T)

Department of Orthopaedic Surgery, Annastift, Hannover Medical School, Hannover, Germany.

Eva M Weissinger (EM)

Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.

Olena Pogozhykh (O)

Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany; REBIRTH Cluster of Excellence, Hannover, Germany.

Thomas Müller (T)

Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany; REBIRTH Cluster of Excellence, Hannover, Germany.

Anton Selich (A)

Institute of Experimental Haematology, Hannover Medical School, Hannover, Germany; REBIRTH Cluster of Excellence, Hannover, Germany.

Michael Rothe (M)

Institute of Experimental Haematology, Hannover Medical School, Hannover, Germany; REBIRTH Cluster of Excellence, Hannover, Germany.

Susanne Petri (S)

Department of Neurology, Hannover Medical School, Hannover, Germany.

Ulrike Köhl (U)

Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany; Institute for Clinical Immunology, University of Leipzig, Leipzig, Germany; Institute for Cellular Therapeutics, Hannover Medical School, Hannover, Germany; REBIRTH Cluster of Excellence, Hannover, Germany.

Ralf Hass (R)

Biochemistry and Tumour Biology Laboratory, Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.

Andrea Hoffmann (A)

Department of Orthopaedic Surgery, Graded Implants and Regenerative Strategies, Hannover Medical School, Hannover, Germany; Lower Saxony Centre for Biomedical Engineering, Implant Research and Development (NIFE), Hannover, Germany. Electronic address: hoffmann.andrea@mh-hannover.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH